Nick Hales: an appreciation of his life and work K. SiddleJ. P. LuzioS. E. Ozanne In Memoriam 29 March 2006 Pages: 1131 - 1133
Early foetal programming of hepatic gluconeogenesis: glucocorticoids strike back C. E. McCurdyJ. E. Friedman Commentary 22 April 2006 Pages: 1138 - 1141
Proinsulin in development: new roles for an ancient prohormone C. Hernández-SánchezA. MansillaF. de Pablo Review 05 April 2006 Pages: 1142 - 1150
Anaemia in diabetes: is there a rationale to TREAT? M. C. ThomasM. E. CooperH. H. Parving For Debate 04 April 2006 Pages: 1151 - 1157
Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetes Belgian Diabetes RegistryI. WeetsF. K. Gorus Short Communication 29 March 2006 Pages: 1158 - 1162
Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes S. LuzioG. DunseathD. R. Owens Article 05 April 2006 Pages: 1163 - 1168
Enhanced soluble CD40L in patients with the metabolic syndrome: relationship with in vivo thrombin generation F. AngelicoC. AlessandriF. Violi Article 29 March 2006 Pages: 1169 - 1174
Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India—the Chennai Urban Rural Epidemiology Study (CURES-17) V. MohanM. DeepaM. Datta Short Communication 29 March 2006 Pages: 1175 - 1178
Increased prevalence of Down’s syndrome in individuals with type 1 diabetes in Denmark: a nationwide population-based study R. BergholdtS. EisingF. Pociot Short Communication 31 March 2006 Pages: 1179 - 1182
Anaemia in diabetic patients with chronic kidney disease—prevalence and predictors S. Al-KhouryB. AfzaliD. J. Goldsmith Article 12 April 2006 Pages: 1183 - 1189
Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype S. E. FlanaganE. L. EdghillA. T. Hattersley Article 12 April 2006 Pages: 1190 - 1197
Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes R. HermannK. LipponenJ. Ilonen Article 14 April 2006 Pages: 1198 - 1208
Common variations in the ALMS1 gene do not contribute to susceptibility to type 2 diabetes in a large white UK population S. PatelJ. A. L. MintonT. G. Barrett Short Communication 07 April 2006 Pages: 1209 - 1213
Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population W. H. LinL. M. ChuangY. T. Chen Article 04 April 2006 Pages: 1214 - 1221
A new model of insulin-deficient diabetes: male NOD mice with a single copy of Ins1 and no Ins2 N. BabayaM. NakayamaG. S. Eisenbarth Article 13 April 2006 Pages: 1222 - 1228
Interferon-γ potentiates endoplasmic reticulum stress-induced death by reducing pancreatic beta cell defence mechanisms P. PirotD. L. EizirikA. K. Cardozo Article 08 April 2006 Pages: 1229 - 1236
Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets J. F. PaulssonA. AnderssonG. T. Westermark Article 29 March 2006 Pages: 1237 - 1246
Exendin-4 treatment improves metabolic control after rat islet transplantation to athymic mice with streptozotocin-induced diabetes A. SharmaA. SörenbyA. Tibell Article 12 April 2006 Pages: 1247 - 1253
The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets S. ZraikaK. Aston-MourneyS. Andrikopoulos Article 29 March 2006 Pages: 1254 - 1263
Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats T. IrakoT. AkamizuK. Kangawa Article 29 March 2006 Pages: 1264 - 1273
Tissue selectivity of insulin detemir action in vivo A. M. HennigeT. SartoriusH.-U. Häring Article 29 March 2006 Pages: 1274 - 1282
Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes K. HøjlundJ. FrystykH. Beck-Nielsen Original 12 April 2006 Pages: 1283 - 1291
Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines J. ChenB. TanH. S. Randeva Article 29 March 2006 Pages: 1292 - 1302
Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone X. SunR. HanY. Chen Article 12 April 2006 Pages: 1303 - 1310
Induction of adiponectin in skeletal muscle of type 2 diabetic mice: in vivo and in vitro studies A. M. DelaigleM. SenouS. M. Brichard Article 29 March 2006 Pages: 1311 - 1323
Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats B. DorfmeisterS. BrandlhoferW. Strobl Article 29 March 2006 Pages: 1324 - 1332
Inhibition of 11β-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice S. J. Y. WangS. BirtlesJ. R. S. Arch Short Communication 13 April 2006 Pages: 1333 - 1337
Insights into the role of anaplerosis in insulin secretion: a 13C NMR study N. E. SimpsonN. KhokhlovaI. Constantinidis Article 31 March 2006 Pages: 1338 - 1348
The equivocal metabolic response to endotoxaemia in type 2 diabetic and obese ZDF rats L. BelabedG. SenonS. Darquy Article 19 April 2006 Pages: 1349 - 1359
Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity D. BoeyS. LinH. Herzog Article 21 April 2006 Pages: 1360 - 1370
Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans C. XiaoA. GiaccaG. F. Lewis Article 05 April 2006 Pages: 1371 - 1379
Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation L. PerségolB. VergèsL. Duvillard Article 05 April 2006 Pages: 1380 - 1386
Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria T. BabazonoK. HanaiY. Iwamoto Article 13 April 2006 Pages: 1387 - 1393
The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients S. BraschiM. GeoffrionR. W. Milne Article 04 April 2006 Pages: 1394 - 1401
Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes V. A. ConstantA. GagnonA. Sorisky Article 12 April 2006 Pages: 1402 - 1411
Prenatal programming of hepatocyte nuclear factor 4α in the rat: a key mechanism in the ‘foetal origins of hyperglycaemia’? M. J. NyirendaS. DeanJ. R. Seckl Article 29 March 2006 Pages: 1412 - 1420
Cardiac overexpression of catalase rescues cardiac contractile dysfunction induced by insulin resistance: role of oxidative stress, protein carbonyl formation and insulin sensitivity F. DongC. X. FangJ. Ren Article 04 April 2006 Pages: 1421 - 1433
Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch S.-Y. LiX. YangJ. Ren Article 13 April 2006 Pages: 1434 - 1446
Diabetic encephalopathy: a concept in need of a definition G. S. MijnhoutP. ScheltensR. J. Heine Letter 06 April 2006 Pages: 1447 - 1448
Characteristics of peripheral arterial disease in Japanese type 2 diabetic patients S. GorogawaO. IidaY. Yamasaki Letter 06 April 2006 Pages: 1449 - 1451
Rat bite as a cause of diabetic foot ulcer—a series of eight cases B. KalraS. KalraH. Singh Letter 04 April 2006 Pages: 1452 - 1453
Risks of troglitazone apparent before approval in USA J. S. Cohen Letter 07 April 2006 Pages: 1454 - 1455
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects M. WalkerA. MariE. Ferrannini Erratum 07 April 2006 Pages: 1456 - 1456
Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden I. WaernbaumG. BlohméL. Nyström Erratum 07 April 2006 Pages: 1457 - 1457
